We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

News   Sep 25, 2020 | Original story from University of New Hampshire

 
University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

Credit: NikolayFrolochkin/Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Ancient DNA Elements Can Activate a Powerful Immune Response to Cancer Cells

News

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

READ MORE

AI Platform Matches Tumor to Most Effective Drug Combo

News

Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA). Ideker and Brent Kuenzi, PhD, and Jisoo Park, PhD, postdoctoral researchers in his lab, describe DrugCell, a new artificial intelligence (AI) system they created that not only matches tumors to the best drug combinations, but does so in a way that makes sense to humans.

READ MORE

Developing a New Staging System for Prostate Cancer

News

Researchers are developing and validating a novel staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE